{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:33:03Z","timestamp":1793291583904,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11882-010-0160-9","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T00:01:53Z","timestamp":1290384113000},"page":"12-20","source":"Crossref","is-referenced-by-count":115,"title":["Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response"],"prefix":"10.1007","volume":"11","author":[{"given":"Justin R.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron S.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"issue":"12","key":"160_CR1","first-page":"1067","volume":"114","author":"RL Kile","year":"1940","unstructured":"Kile RL, Rusk HA. A case of cold urticaria with an unusual family history. J Am Med Assoc. 1940, 114(12):1067-1068.","journal-title":"J Am Med Assoc."},{"issue":"6","key":"160_CR2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1185\/03007990802081543","volume":"24","author":"B Stych","year":"2008","unstructured":"Stych B, Dobrovolny D. Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients\u2019 lives. Curr Med Res Opin. 2008, 24(6):1577-1582.","journal-title":"Curr Med Res Opin."},{"issue":"6","key":"160_CR3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1469-8749.2009.03336.x","volume":"51","author":"GA Montealegre Sanchez","year":"2009","unstructured":"Montealegre Sanchez GA, Hashkes PJ. Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes. Dev Med Child Neurol. 2009, 51(6):420-428.","journal-title":"Dev Med Child Neurol"},{"key":"160_CR4","first-page":"235","volume":"31","author":"TJ Muckle","year":"1962","unstructured":"Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q. J. Med. 1962, 31:235-248.","journal-title":"Q. J. Med."},{"issue":"11","key":"160_CR5","first-page":"1070","volume":"66","author":"J Lorber","year":"1973","unstructured":"Lorber J. Syndrome for diagnosis: dwarfing, persistently open fontanelle; recurrent meningitis; recurrent subdural effusions with temporary alternate-sided hemiplegia; high-tone deafness; visual defect with pseudopapilloedema; slowing intellectual development; recurrent acute polyarthritis; erythema marginatum, splenomegaly and iron-resistant hypochromic anaemia. Proc. R. Soc. Med. 1973, 66(11):1070-1071.","journal-title":"Proc. R. Soc. Med."},{"issue":"6","key":"160_CR6","first-page":"1171","volume":"22","author":"A Huttenlocher","year":"1995","unstructured":"Huttenlocher A, Frieden IJ, Emery H. Neonatal onset multisystem inflammatory disease. J. Rheumatol. 1995, 22(6):1171-1173.","journal-title":"J. Rheumatol."},{"issue":"2","key":"160_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archderm.141.2.248","volume":"141","author":"C Kilcline","year":"2005","unstructured":"Kilcline C, Shinkai K, Bree A, et al. Neonatal-Onset Multisystem Inflammatory Disorder: The Emerging Role of Pyrin Genes in Autoinflammatory Diseases. Arch Dermatol. 2005, 141(2):248-253.","journal-title":"Arch Dermatol."},{"issue":"12","key":"160_CR8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.142.12.1591","volume":"142","author":"KS Leslie","year":"2006","unstructured":"Leslie KS, Lachmann HJ, Bruning E, et al. Phenotype, Genotype, and Sustained Response to Anakinra in 22 Patients With Autoinflammatory Disease Associated With CIAS-1\/NALP3 Mutations. Arch Dermatol. 2006, 142(12):1591-1597.","journal-title":"Arch Dermatol."},{"issue":"1","key":"160_CR9","first-page":"1","volume":"33","author":"K Shinkai","year":"2008","unstructured":"Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin. Exp. Dermatol. 2008, 33(1):1-9.","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"160_CR10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijporl.2010.02.023","volume":"74","author":"D Biswas","year":"2010","unstructured":"Biswas D, Stafford N. Otolaryngological manifestations of \u2018Muckle-Wells syndrome\u2019. Int. J. Pediatr. Otorhinolaryngol. 2010, 74(5):553-555.","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"1","key":"160_CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","volume":"62","author":"B Neven","year":"2010","unstructured":"Neven B, Marvillet I, Terrada C, et al. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2010, 62(1):258-267.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"160_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 2006, 355(6):581-592.","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"160_CR13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.21807","volume":"54","author":"T Mirault","year":"2006","unstructured":"Mirault T, Launay D, Cuisset L, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum. 2006, 54(5):1697-1700.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"160_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00247-006-0358-0","volume":"37","author":"SC Hill","year":"2007","unstructured":"Hill SC, Namde M, Dwyer A, et al. Arthropathy of neonatal onset multisystem inflammatory disease (NOMID\/CINCA). Pediatr Radiol. 2007, 37(2):145-152.","journal-title":"Pediatr Radiol."},{"issue":"1","key":"160_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","volume":"71","author":"J Feldmann","year":"2002","unstructured":"Feldmann J, Prieur A, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 2002, 71(1):198-203.","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"160_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001, 29(3):301-305.","journal-title":"Nat Genet."},{"issue":"6","key":"160_CR17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2009.11.016","volume":"124","author":"R Goldbach-Mansky","year":"2009","unstructured":"Goldbach-Mansky R, Kastner DL. Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. Journal of Allergy and Clinical Immunology. 2009, 124(6):1141-1149.","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"4","key":"160_CR18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.27342","volume":"62","author":"JI Ar\u00f3stegui","year":"2010","unstructured":"Ar\u00f3stegui JI, Lopez Salda\u00f1a MD, Pascal M, et al. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome\/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases. Arthritis Rheum. 2010, 62(4):1158-1166.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"160_CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clim.2010.02.013","volume":"135","author":"C Henderson","year":"2010","unstructured":"Henderson C, Goldbach-Mansky R. Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: Finding the right balance in response to danger signals. Clinical Immunology. 2010, 135(2):210-222.","journal-title":"Clinical Immunology."},{"issue":"1","key":"160_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coi.2008.01.003","volume":"20","author":"Z Ye","year":"2008","unstructured":"Ye Z, Ting JP. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 2008, 20(1):3-9.","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"160_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004, 20(3):319-325.","journal-title":"Immunity."},{"issue":"21","key":"160_CR22","doi-asserted-by":"crossref","first-page":"21924","DOI":"10.1074\/jbc.M401178200","volume":"279","author":"TA Dowds","year":"2004","unstructured":"Dowds TA, Masumoto J, Zhu L, et al. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 2004, 279(21):21924-21928.","journal-title":"J. Biol. Chem."},{"issue":"21","key":"160_CR23","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1073\/pnas.1000779107","volume":"107","author":"S Tassi","year":"2010","unstructured":"Tassi S, Carta S, Delfino L, et al. Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(21):9789-9794.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"160_CR24","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1542\/peds.114.1.e124","volume":"114","author":"S Stojanov","year":"2004","unstructured":"Stojanov S, Weiss M, Lohse P, Belohradsky BH. A Novel CIAS1 Mutation and Plasma\/Cerebrospinal Fluid Cytokine Profile in a German Patient With Neonatal-Onset Multisystem Inflammatory Disease Responsive to Methotrexate Therapy. Pediatrics. 2004, 114(1):e124-127.","journal-title":"Pediatrics."},{"issue":"6","key":"160_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.pediatrneurol.2009.06.008","volume":"41","author":"M Serrano","year":"2009","unstructured":"Serrano M, Ormaz\u00e1bal A, Ant\u00f3n J, et al. Cerebrospinal Fluid Neopterin and Cryopyrin-Associated Periodic Syndrome. Pediatric Neurology. 2009, 41(6):448-450.","journal-title":"Pediatric Neurology."},{"issue":"8","key":"160_CR26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/sj.jid.5700819","volume":"127","author":"H Watanabe","year":"2007","unstructured":"Watanabe H, Gaide O, P\u00e9trilli V, et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 2007, 127(8):1956-1963.","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"160_CR27","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","volume":"46","author":"E Aganna","year":"2002","unstructured":"Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002, 46(9):2445-2452.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"160_CR28","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis & Rheumatism. 2002, 46(12):3340-3348.","journal-title":"Arthritis & Rheumatism."},{"key":"160_CR29","unstructured":"Hoffman, H. Infevers - NLRP3 Sequence Variants. http:\/\/fmf.igh.cnrs.fr\/ISSAID\/infevers\/search.php?n=4 . Accessed September 20, 2010."},{"issue":"4","key":"160_CR30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/art.22491","volume":"56","author":"ID Aksentijevich","year":"2007","unstructured":"Aksentijevich I, D. Putnam C, Remmers EF, et al. The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007, 56(4):1273-1285","journal-title":"Arthritis Rheum"},{"issue":"2","key":"160_CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-007-9150-7","volume":"28","author":"A Jesus","year":"2008","unstructured":"Jesus A, Silva C, Segundo G, et al. Phenotype\u2013Genotype Analysis of Cryopyrin-Associated Periodic Syndromes (CAPS): Description of a Rare Non-Exon 3 and a Novel CIAS1 Missense Mutation. Journal of Clinical Immunology. 2008, 28(2):134-138.","journal-title":"Journal of Clinical Immunology."},{"issue":"4","key":"160_CR32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11882-010-0121-3","volume":"10","author":"K Krause","year":"2010","unstructured":"Krause K, Zuberbier T, Maurer M. Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010,10(4):243-249.","journal-title":"Curr Allergy Asthma Rep."},{"issue":"3","key":"160_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2230.2007.02376.x","volume":"32","author":"F Siebenhaar","year":"2007","unstructured":"Siebenhaar F, Weller K, Mlynek A, et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin. Exp. Dermatol. 2007, 32(3):241-245.","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"160_CR34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerr\u00e9","year":"2008","unstructured":"Lequerr\u00e9 T, Quartier P, Rosellini D, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann. Rheum. Dis. 2008, 67(3):302-308.","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"160_CR35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1600-0560.2010.01570.x","volume":"37","author":"RR Fortna","year":"2010","unstructured":"Fortna RR, Gudjonsson JE, Seidel G, et al. Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still\u2019s disease. J. Cutan. Pathol. 2010, 37(9):932-937.","journal-title":"J. Cutan. Pathol."},{"issue":"6","key":"160_CR36","first-page":"421","volume":"24","author":"M Frieri","year":"2003","unstructured":"Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 2003, 24(6): 421-9.","journal-title":"Allergy Asthma Proc."},{"issue":"4","key":"160_CR37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/ken030","volume":"47","author":"V Ohlsson","year":"2008","unstructured":"Ohlsson V, Baildam E, Foster H, et al. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford). 2008, 47(4):555-556.","journal-title":"Rheumatology (Oxford)."},{"issue":"9","key":"160_CR38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 2005, 201(9):1479-1486.","journal-title":"J. Exp. Med."},{"issue":"3","key":"160_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.41.3.259","volume":"41","author":"M Gwyther","year":"1982","unstructured":"Gwyther M, Schwarz H, Howard A, Ansell BM. C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis. Ann. Rheum. Dis. 1982, 41(3):259-262","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"160_CR40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still\u2019s disease. Ann. Rheum. Dis. 2006, 65(5):564-572","journal-title":"Ann. Rheum. Dis"},{"issue":"23","key":"160_CR41","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","volume":"360","author":"S Reddy","year":"2009","unstructured":"Reddy S, Jia S, Geoffrey R, et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N. Engl. J. Med. 2009, 360(23):2438-2444.","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"160_CR42","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 2009, 360(23):2426-2437.","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"160_CR43","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1111\/j.1365-2230.2009.03746.x","volume":"35","author":"A Asahina","year":"2010","unstructured":"Asahina A, Sakurai N, Suzuki Y, Narushima K. Schnitzler\u2019s syndrome with prominent neutrophil infiltration misdiagnosed as Sweet\u2019s syndrome: a typical example of urticarial neutrophilic dermatosis. Clin. Exp. Dermatol. 2010, 35(4):e123-126.","journal-title":"Clin. Exp. Dermatol."},{"issue":"4","key":"160_CR44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","volume":"65","author":"HD Koning de","year":"2006","unstructured":"de Koning HD, Bodar EJ, Simon A, et al. Beneficial response to anakinra and thalidomide in Schnitzler\u2019s syndrome. Ann. Rheum. Dis. 2006, 65(4):542-544.","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"160_CR45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jbspin.2007.07.014","volume":"75","author":"M Soubrier","year":"2008","unstructured":"Soubrier M. Schnitzler syndrome. Joint Bone Spine. 2008, 75(3):263-266.","journal-title":"Joint Bone Spine."},{"issue":"9275","key":"160_CR46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","volume":"358","author":"JD Gillmore","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001, 358(9275):24-29.","journal-title":"Lancet."},{"issue":"9","key":"160_CR47","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V79.9.2196.2196","volume":"79","author":"E Fischer","year":"1992","unstructured":"Fischer E, Van Zee KJ, Marano MA, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 1992, 79(9):2196-2200.","journal-title":"Blood."},{"issue":"7","key":"160_CR48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/art.1780390704","volume":"39","author":"GV Campion","year":"1996","unstructured":"Campion GV, Lebsack ME, Lookabaugh J, et al. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum. 1996, 39(7):1092-1101.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"160_CR49","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 2007, 9(2):R28.","journal-title":"Arthritis Res. Ther."},{"key":"160_CR50","unstructured":"Kineret [package insert]. Thousand Oaks, CA: Amgen Manufacturing, Limited, 2001-2003."},{"issue":"5","key":"160_CR51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI115748","volume":"89","author":"E Fischer","year":"1992","unstructured":"Fischer E, Marano MA, Van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 1992, 89(5):1551-1557.","journal-title":"J. Clin. Invest."},{"issue":"1","key":"160_CR52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-199401000-00267","volume":"22","author":"CJ Fisher","year":"1994","unstructured":"Fisher CJ, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit. Care Med. 1994, 22(1):12-21.","journal-title":"Crit. Care Med."},{"issue":"23","key":"160_CR53","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.271.23.1836","volume":"271","author":"CJ Fisher","year":"1994","unstructured":"Fisher CJ, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994, 271(23):1836-1843.","journal-title":"JAMA"},{"issue":"5","key":"160_CR54","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P","volume":"43","author":"Y Jiang","year":"2000","unstructured":"Jiang Y, Genant HK, Watt I, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 2000, 43(5):1001-1009.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"160_CR55","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","volume":"41","author":"B Bresnihan","year":"1998","unstructured":"Bresnihan B, Alvaro-Gracia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998, 41(12):2196-2204.","journal-title":"Arthritis Rheum."},{"issue":"25","key":"160_CR56","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJM200306193482523","volume":"348","author":"PN Hawkins","year":"2003","unstructured":"Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N. Engl. J. Med. 2003, 348(25):2583-2584.","journal-title":"N. Engl. J. Med."},{"issue":"9447","key":"160_CR57","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, Rosengren S, Boyle DL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004, 364(9447):1779-1785.","journal-title":"Lancet."},{"issue":"2","key":"160_CR58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"PN Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004, 50(2):607-612.","journal-title":"Arthritis Rheum."},{"issue":"8","key":"160_CR59","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh652","volume":"44","author":"E Ramos","year":"2005","unstructured":"Ramos E, Ar\u00f3stegui JI, Campuzano S, et al. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology (Oxford). 2005, 44(8):1072-1073.","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"160_CR60","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ajmg.a.31148","volume":"140","author":"C Boschan","year":"2006","unstructured":"Boschan C, Witt O, Lohse P, et al. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. Am. J. Med. Genet. A. 2006,140(8):883-886.","journal-title":"Am. J. Med. Genet. A."},{"issue":"2","key":"160_CR61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/039463201002300226","volume":"23","author":"N Cascavilla","year":"2010","unstructured":"Cascavilla N, Bisceglia M, D\u2019Arena G. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Int J Immunopathol Pharmacol. 2010, 23(2):633-636.","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"3","key":"160_CR62","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1111\/j.1756-185X.2010.01474.x","volume":"13","author":"M Lahiri","year":"2010","unstructured":"Lahiri M, Teng G. A case of refractory adult-onset Still's disease treated with anakinra. Int J Rheum Dis. 2010, 13(3):e36-41.","journal-title":"Int J Rheum Dis."},{"issue":"10","key":"160_CR63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","volume":"105","author":"A Abbate","year":"2010","unstructured":"Abbate A, Kontos MC, Grizzard JD, et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am. J. Cardiol. 2010, 105(10):1371-1377.e1.","journal-title":"Am. J. Cardiol"},{"issue":"1","key":"160_CR64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","volume":"9","author":"AN Economides","year":"2003","unstructured":"Economides AN, Carpenter LR, Rudge JS, et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 2003, 9(1):47-52.","journal-title":"Nat. Med."},{"key":"160_CR65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1749-6632.2009.05074.x","volume":"1182","author":"N Stahl","year":"2009","unstructured":"Stahl N, Radin A, Mellis S. Rilonacept--CAPS and beyond. Ann. N. Y. Acad. Sci. 2009, 1182:124-134.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"160_CR66","unstructured":"Arcalyst [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2008."},{"issue":"8","key":"160_CR67","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","volume":"58","author":"R Goldbach-Mansky","year":"2008","unstructured":"Goldbach-Mansky R, Shroff SD, Wilson M, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 2008, 58(8):2432-2442.","journal-title":"Arthritis Rheum."},{"issue":"8","key":"160_CR68","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"HM Hoffman","year":"2008","unstructured":"Hoffman HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 2008, 58(8):2443-2452.","journal-title":"Arthritis Rheum."},{"issue":"10","key":"160_CR69","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","volume":"68","author":"R Terkeltaub","year":"2009","unstructured":"Terkeltaub R, Sundy JS, Schumacher HR, et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann. Rheum. Dis. 2009, 68(10):1613-1617.","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"160_CR70","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","volume":"206","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Lowe P, Felix SD, et al. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J. Exp. Med. 2009, 206(5):1029-1036.","journal-title":"J. Exp. Med."},{"key":"160_CR71","unstructured":"Ilaris [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2009."},{"issue":"23","key":"160_CR72","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"\u2022 Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 2009, 360(23):2416-2425. This showed that canakinumab, a fully human monoclonal antibody against IL-1\u03b2, had sustained efficacy in the treatment of CAPS.","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"160_CR73","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/ar2438","volume":"10","author":"R Alten","year":"2008","unstructured":"Alten R, Gram H, Joosten LA, et al. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res. Ther. 2008, 10(3):R67.","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"160_CR74","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","volume":"62","author":"A So","year":"2010","unstructured":"So A, De Meulemeester M, Pikhlak A, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 2010, 62(10):3064-3076.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"160_CR75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"W Wannamaker","year":"2007","unstructured":"Wannamaker W, Davies R, Namchuk M, et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3\u00a0S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J. Pharmacol. Exp. Ther. 2007, 321(2):509-516.","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"160_CR76","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","volume":"175","author":"JH Stack","year":"2005","unstructured":"Stack JH, Beaumont K, Larsen PD, et al. IL-converting enzyme\/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J. Immunol. 2005, 175(4):2630-2634.","journal-title":"J. Immunol."},{"issue":"9","key":"160_CR77","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1185\/03007990802297495","volume":"24","author":"HM Hoffman","year":"2008","unstructured":"Hoffman HM, Wolfe F, Belomestnov P, Mellis SJ. Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity. Curr Med Res Opin. 2008, 24(9):2531-2543.","journal-title":"Curr Med Res Opin."},{"issue":"5","key":"160_CR78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/ar2509","volume":"10","author":"A So","year":"2008","unstructured":"So A. Developments in the scientific and clinical understanding of gout. Arthritis Res. Ther. 2008;10(5):221.","journal-title":"Arthritis Res. Ther"},{"issue":"5","key":"160_CR79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Ruzicka T, Plewig G, et al. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br. J. Dermatol. 2009,161(5):1199-1201.","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"160_CR80","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14712590903136688","volume":"9","author":"K Maedler","year":"2009","unstructured":"Maedler K, Dharmadhikari G, Schumann DM, St\u00f8rling J. Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther. 2009, 9(9):1177-1188.","journal-title":"Expert Opin Biol Ther."},{"issue":"7293","key":"160_CR81","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010, 464(7293):1357-1361.","journal-title":"Nature."}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11882-010-0160-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T20:33:28Z","timestamp":1592080408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-010-0160-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s11882-010-0160-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}